Moalifeplus (CEO Han Sangjin) announced on October 22 that its independently developed next-generation universal vaccine platform technology has ...

Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it ...

Avoid financial surprises when getting your puppy’s first shots.

"RNA vaccines and adenovirus-based vaccines (technologies used to develop vaccines against Covid-19) are already in phase two human trials for other infectious diseases like influenza and a different ...

A combination of children returning to school, adults back at work after the summer break and people spending more time ...

MONROE, La. (KNOE) - Meet Gruff! Humane Society Adoption Center of Monroe Director Terri Matthews says Gruff is about 3 and a half months old, and he has a condition that is the equivalent of down ...

AstraZeneca's suspension of global trials of its experimental coronavirus vaccine after an illness in a study subject in Britain has cast doubt on prospects for an early rollout of one of the most ...

The modified common cold viruses behind high-profile COVID-19 vaccine candidates from China's CanSino Biologics and Russia's Gamaleya Institute have been studied for decades, but are still not widely ...

The UK Health and Security Agency (UKHSA) has issued guidance to households all over the UK in order to help people identify ...

Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today ...

The Centers for Disease Control and Prevention updated its guidance for the COVID-19 vaccine Monday, ending months of confusion about the vaccine in Illinois. The new guidance advises people 65 and ...